PB
Propel Bio Management, LLC
13F filer · CIK 0001969764Reported Aug 13, 2026
Net seller this quarter
13F portfolio value$191MU.S. long equity reported on 13F
Positions293 new · 12 closed
Net flow last quarter-$7.61MBuys minus sells
Top 10 positions weight68.1%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 13, 202629 positions | |||||
| $30.9M | 16.16% | 0.64% | Not reported | Q4 2023 | |
| $26.3M | 13.79% | 3.93% | +6.5% | Q1 2024 | |
| $11.9M | 6.21% | 0.13% | -7.7% | Q1 2026 | |
| $11.4M | 5.96% | 1.31% | +24.9% | Q4 2023 | |
| $11M | 5.74% | 2.52% | -11.1% | Q4 2024 | |
| $9.96M | 5.21% | 5.97% | +80.4% | Q1 2025 | |
| $8.11M | 4.24% | 0.42% | -22.8% | Q3 2024 | |
| $7.87M | 4.12% | 1.43% | +37.1% | Q4 2025 | |
| $6.76M | 3.54% | 2.82% | +375.8% | Q1 2026 | |
| $6.08M | 3.18% | 1.72% | -26.1% | Q2 2024 | |
| $6M | 3.14% | 1.15% | +102.9% | Q1 2026 | |
| $5.4M | 2.82% | 1.49% | +131.6% | Q1 2026 | |
| $5M | 2.61% | 2.38% | +38.6% | Q1 2026 | |
| $4.84M | 2.53% | 0.66% | +76.8% | Q4 2025 | |
| $4.2M | 2.20% | 1.29% | +6.3% | Q4 2025 | |
| $3.87M | 2.02% | 1.49% | Not reported | Q1 2026 | |
| $3.86M | 2.02% | 0.13% | -21.1% | Q3 2025 | |
| $3.64M | 1.90% | 0.43% | -10.2% | Q3 2024 | |
| $3.52M | 1.84% | 0.16% | -6.4% | Q1 2026 | |
| $3.36M | 1.76% | 0.46% | -33.6% | Q1 2026 | |
| $3M | 1.57% | 0.60% | +21.1% | Q1 2026 | |
| $2.74M | 1.43% | 0.23% | -11.2% | Q1 2026 | |
| $2.42M | 1.27% | 0.64% | +2.5% | Q1 2026 | |
| $2.21M | 1.16% | 5.46% | New | Q2 2026 | |
| $2.11M | 1.10% | 0.14% | New | Q2 2026 | |
| $1.37M | 0.72% | 1.58% | Not reported | Q3 2025 | |
| $1.31M | 0.68% | 0.08% | Not reported | Q1 2026 | |
| $1.05M | 0.55% | 0.08% | -18.0% | Q1 2026 | |
| $973K | 0.51% | 0.41% | New | Q2 2026 | |
| Q1 2026Reported May 14, 202638 positions | |||||
| $30.2M | 19.02% | 0.64% | Not reported | Q4 2023 | |
| $11.4M | 7.17% | 7.11% | Not reported | Q1 2024 | |
| $9.35M | 5.90% | 1.06% | +13.5% | Q4 2023 | |
| $9.16M | 5.77% | 2.84% | +123.4% | Q4 2024 | |
| $6.02M | 3.80% | 0.14% | New | Q1 2026 | |
| $6.01M | 3.79% | 2.34% | +60.1% | Q2 2024 | |
| $5.59M | 3.52% | 0.58% | New | Q1 2026 | |
| $5.59M | 3.52% | 1.06% | -3.3% | Q4 2025 | |
| $5.08M | 3.20% | 3.50% | Not reported | Q1 2025 | |
| $4.14M | 2.61% | 0.20% | -14.9% | Q3 2025 | |
| $4.12M | 2.60% | 0.55% | -13.9% | Q3 2024 | |
| $4.09M | 2.58% | 0.21% | -25.6% | Q3 2025 | |
| $3.99M | 2.52% | 0.38% | -27.5% | Q4 2025 | |
| $3.89M | 2.45% | 1.34% | +55.1% | Q4 2025 | |
| $3.83M | 2.41% | 1.53% | New | Q1 2026 | |
| $3.58M | 2.26% | 0.73% | New | Q1 2026 | |
| $3.28M | 2.07% | Not reported | -29.3% | Q4 2025 | |
| $3.23M | 2.03% | 0.17% | New | Q1 2026 | |
| $3.1M | 1.95% | 0.63% | New | Q1 2026 | |
| $2.95M | 1.86% | 0.57% | New | Q1 2026 | |
| $2.79M | 1.76% | 0.26% | New | Q1 2026 | |
| $2.65M | 1.67% | 0.17% | Not reported | Q1 2024 | |
| $2.64M | 1.66% | 0.48% | +343.5% | Q3 2024 | |
| $2.62M | 1.65% | 17.21% | New | Q1 2026 | |
| $2.41M | 1.52% | 0.92% | New | Q1 2026 | |
| $2.04M | 1.28% | 0.55% | New | Q1 2026 | |
| $2M | 1.26% | 0.67% | New | Q1 2026 | |
| $1.72M | 1.08% | 1.29% | +603.3% | Q4 2025 | |
| $1.71M | 1.08% | 0.17% | New | Q1 2026 | |
| $1.5M | 0.94% | 1.59% | Not reported | Q3 2025 | |
| $1.41M | 0.89% | 0.10% | New | Q1 2026 | |
| $1.31M | 0.82% | 0.09% | New | Q1 2026 | |
| $1.28M | 0.81% | 0.15% | New | Q1 2026 | |
| $1.25M | 0.79% | 0.10% | New | Q1 2026 | |
| $1.23M | 0.78% | 1.21% | New | Q1 2026 | |
| $950K | 0.60% | 0.59% | New | Q1 2026 | |
| $554K | 0.35% | 0.33% | New | Q1 2026 | |
| $57.1K | 0.04% | 0.79% | New | Q1 2026 | |
| Q4 2025Reported Feb 11, 202620 positions | |||||
| $24.4M | 20.79% | 0.64% | Not reported | Q4 2023 | |
| $18.8M | 16.07% | 7.11% | Not reported | Q1 2024 | |
| $12.3M | 10.49% | 1.04% | +34.0% | Q4 2023 | |
| $8.79M | 7.51% | 0.28% | +213.9% | Q3 2025 | |
| $8.32M | 7.10% | 3.88% | -19.6% | Q1 2025 | |
| $6.27M | 5.35% | 1.10% | New | Q4 2025 | |
| $5.95M | 5.08% | 0.90% | +69.0% | Q3 2024 | |
| $4.65M | 3.97% | 0.52% | New | Q4 2025 | |
| $4.43M | 3.78% | 1.26% | Not reported | Q4 2024 | |
| $4.38M | 3.74% | 1.51% | -14.7% | Q2 2024 | |
| $4.19M | 3.58% | 0.23% | -0.5% | Q3 2025 | |
| $3.5M | 2.99% | 0.41% | +69.0% | Q3 2025 | |
| $3.45M | 2.95% | Not reported | New | Q4 2025 | |
| $2.44M | 2.08% | 1.37% | New | Q4 2025 | |
| $1.68M | 1.44% | 0.23% | New | Q4 2025 | |
| $1.13M | 0.96% | 1.60% | Not reported | Q3 2025 | |
| $945K | 0.81% | 0.19% | New | Q4 2025 | |
| $609K | 0.52% | 0.21% | New | Q4 2025 | |
| $571K | 0.49% | 0.11% | -72.5% | Q3 2024 | |
| $355K | 0.30% | 0.18% | New | Q4 2025 | |
| Q3 2025Reported Nov 12, 202516 positions | |||||
| $23.2M | 23.23% | 0.64% | Not reported | Q4 2023 | |
| $11.9M | 11.94% | 7.17% | -38.5% | Q1 2024 | |
| ATAKROAkero Therapeutics, Inc. | $10.9M | 10.88% | 0.29% | Not reported | Q4 2023 |
| $10.2M | 10.26% | 6.02% | +186.1% | Q1 2025 | |
| ATAPLTApplied Therapeutics, Inc. | $6.83M | 6.83% | 7.82% | Not reported | Q4 2023 |
| $6.51M | 6.51% | 0.78% | -40.1% | Q4 2023 | |
| $5.14M | 5.15% | 1.86% | Not reported | Q2 2024 | |
| $4.71M | 4.72% | 1.24% | +94.0% | Q4 2024 | |
| $4.01M | 4.01% | 0.23% | New | Q3 2025 | |
| $3.52M | 3.52% | 8.06% | -7.4% | Q4 2023 | |
| $2.92M | 2.93% | 0.53% | Not reported | Q3 2024 | |
| $2.79M | 2.79% | 0.25% | New | Q3 2025 | |
| $2.45M | 2.45% | 3.68% | Not reported | Q4 2024 | |
| $2.21M | 2.21% | 0.41% | Not reported | Q3 2024 | |
| $1.94M | 1.94% | 0.11% | New | Q3 2025 | |
| $618K | 0.62% | 3.79% | New | Q3 2025 | |
Premium opens every quarter this fund has filed